In contrast, previous studies [28, 29] have identified TRIM56 as a tumor suppressor through activation of TLR3/TRIF signaling pathway, which was consistent with the result that TRIM56 expression was a favorable indicator of MIBC in this study. Here, TLR3 is linked to neoplasm.